Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Hempalta Provides Strategic Update Regarding Equipment Sale and FCC Agreement June 7, 2025 Top 5 Canadian Mining Stocks This Week: Africa Energy Jumps 275 Percent June 7, 2025 Crypto Market Recap: Strategy Eyes US$1 Billion Capital Raise, Uber Considers Stablecoin Usage June 7, 2025
Crypto Market Recap: Strategy Eyes US$1 Billion Capital Raise, Uber Considers Stablecoin Usage June 7, 2025